Index
RUT
Market Cap
4.20B
Enterprise Value
4.34B
Income
-13.95M
Sales
825.34M
Book/sh
5.65
Cash/sh
17.94
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
2400
IPO
Oct 20, 2016
P/E
-
Forward P/E
113.01
PEG
-
P/S
5.09
P/B
22.59
P/C
7.11
P/FCF
107.83
EV/EBITDA
114.10
EV/Sales
5.26
Quick Ratio
3.74
Current Ratio
3.85
Debt/Eq
3.91
LT Debt/Eq
3.82
Option/Short
Yes / Yes
EPS (ttm)
-0.43
EPS next Y
1.13
EPS next Q
0.02
EPS this Y
84.17%
EPS next Y
612.88%
EPS next 5Y
-
EPS past 3/5Y
28.96% 2.49%
Sales past 3/5Y
22.05% 23.02%
EPS Y/Y TTM
85.38%
Sales Y/Y TTM
25.58%
EPS Q/Q
97.39%
Sales Q/Q
20.08%
Insider Own
2.09%
Insider Trans
-8.68%
Inst Own
105.64%
Inst Trans
-4.03%
ROA
-1.36%
ROE
-9.63%
ROIC
-1.56%
Gross Margin
71.45%
Oper. Margin
1.38%
Profit Margin
-1.69%
SMA20
12.25%
SMA50
10.76%
SMA200
4.18%
Trades
Shs Outstand
32.94M
Shs Float
32.27M
52W High
212.00 -39.85%
52W Low
100.70 26.62%
Volatility
3.63% 3.67%
ATR (14)
4.17
RSI (14)
73.20
Beta
1.41
Rel Volume
0.08
Avg Volume
565.97K
Volume
2,398
Perf Week
5.15%
Perf Month
14.82%
Perf Quarter
2.29%
Perf Half Y
5.55%
Perf YTD
-28.14%
Perf Year
-30.75%
Perf 3Y
65.99%
Perf 5Y
81.79%
Perf 10Y
425.81%
Prev Close
127.80
Price
127.51
Change %
-0.23%
Analysts 13 incl. previous ratings
Rating Distribution 12 Buy · 1 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 16, 2026 Initiated P Piper Sandler
Overweight $160 +25.5% Jul 23, 2026 Initiated S Stephens
Overweight $160 +25.5% Jan 05, 2026 Upgrade E Evercore ISI
In-line → Outperform $210 +64.7% Sep 23, 2025 Initiated E Evercore ISI
In-line $185 +45.1% Aug 20, 2025 Initiated B BofA Securities
Buy $200 +56.9% May 02, 2025 Upgrade W Wells Fargo
Equal Weight → Overweight $130 +2.0% Dec 03, 2024 Resumed W Wells Fargo
Equal Weight $86 -32.6% Oct 04, 2024 Initiated G Goldman
Neutral $78 -38.8% Jun 20, 2024 Upgrade W Wolfe Research
Peer Perform → Outperform $115 -9.8% Dec 11, 2023 Upgrade C Citigroup
Neutral → Buy $110 -13.7% Jul 19, 2023 Initiated R Robert W. Baird
Outperform $130 +2.0% Feb 07, 2023 Initiated W Wells Fargo
Overweight $150 +17.6% Nov 07, 2022 Upgrade W Wolfe Research
Underperform → Peer Perform Jun 09, 2022 Downgrade C Citigroup
Buy → Neutral $180 → $155 +21.6% Apr 06, 2022 Initiated W Wolfe Research
Underperform $105 -17.7% Feb 24, 2022 Upgrade N Needham
Hold → Buy $135 +5.9% Feb 24, 2022 Upgrade N Needham
Hold → Buy Jan 18, 2022 Upgrade M Morgan Stanley
Equal-Weight → Overweight $129 → $167 +31.0% Jan 12, 2022 Upgrade B BTIG Research
Neutral → Buy $170 +33.3% Jan 11, 2022 Upgrade O Oppenheimer
Perform → Outperform $150 +17.6%
Show Previous Ratings
Oct-28-26 08:11PM
Oct-15-26 04:05PM
Oct-13-26 03:19PM
Oct-05-26 09:05AM
Oct-02-26 04:41PM
04:50PM
Loading…
Sep-24-26 04:50PM
Aug-26-26 04:05PM
Aug-17-26 03:35AM
Aug-10-26 07:00AM
Aug-07-26 04:27PM
11:24AM
01:06AM
Aug-06-26 04:06PM
04:05PM
Jul-29-26 11:00AM
04:05PM
Loading…
Jul-16-26 04:05PM
Jul-03-26 12:38PM
Jun-16-26 09:11AM
May-29-26 07:19AM
May-19-26 04:05PM
May-01-26 03:20AM
Apr-30-26 04:05PM
Apr-28-26 04:05PM
Apr-27-26 08:05AM
Apr-16-26 04:05PM
Apr-09-26 06:44PM
Mar-30-26 08:05AM
Mar-12-26 04:30PM
Mar-11-26 05:25AM
Mar-02-26 01:45PM
10:50AM
Loading…
10:50AM
Feb-23-26 12:00PM
Feb-19-26 10:07PM
05:40PM
05:18PM
04:05PM
Feb-17-26 10:04PM
Feb-05-26 04:30PM
Feb-04-26 11:36PM
Jan-30-26 02:31PM
08:57AM
Jan-29-26 05:02PM
Jan-20-26 10:34PM
12:08PM
Jan-15-26 11:22AM
06:53AM
Jan-14-26 12:43PM
09:57AM
Jan-13-26 07:43AM
Jan-12-26 04:18PM
(Investor's Business Daily)
-5.82%
08:26AM
07:30AM
Jan-07-26 11:05PM
Dec-29-25 04:30PM
Dec-22-25 03:01PM
09:53AM
Dec-05-25 02:25PM
10:22AM
Nov-30-25 03:18PM
Nov-21-25 08:10AM
Nov-11-25 08:05AM
Nov-06-25 12:38AM
Nov-05-25 01:38PM
Nov-04-25 04:30PM
Oct-31-25 07:35PM
01:01PM
08:40AM
Oct-30-25 11:03PM
05:45PM
04:18PM
04:05PM
Oct-28-25 11:13PM
Oct-23-25 05:00PM
Oct-20-25 06:31AM
Oct-16-25 04:30PM
Oct-05-25 11:35PM
Oct-01-25 12:32AM
Sep-30-25 12:35PM
Sep-23-25 09:40AM
Sep-12-25 08:34AM
Sep-11-25 12:39AM
Sep-02-25 01:32PM
Sep-01-25 12:01AM
Aug-29-25 07:00AM
Aug-22-25 09:03AM
Aug-20-25 04:30PM
12:34AM
Aug-18-25 09:00AM
08:05AM
Aug-13-25 03:00PM
12:08AM
12:05AM
Aug-01-25 12:21PM
03:37AM
Jul-31-25 05:40PM
04:54PM
04:10PM
04:05PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Wilson Daniel G. Chief Financial Officer Sep 02 '26 Sale 121.83 773 94,175 34,887 Sep 03 04:01 PM Blackford Quentin S. President and CEO Aug 10 '26 Sale 124.65 26,859 3,348,012 226,008 Aug 11 04:02 PM Murphy Patrick Michael CBO and CLO Aug 10 '26 Sale 124.65 7,093 884,156 69,699 Aug 11 04:02 PM Patterson Chad CHIEF COMM & PRODUCT OFFICER Aug 10 '26 Sale 124.65 7,093 884,170 62,125 Aug 11 04:01 PM Shrishrimal Sumi EVP, Chief Risk Officer Aug 10 '26 Sale 124.65 5,372 669,641 44,621 Aug 11 04:01 PM Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH Aug 10 '26 Sale 124.65 7,093 884,151 60,116 Aug 11 04:00 PM Smith Mervin EVP Strategic Business Ops Aug 03 '26 Sale 122.12 617 75,349 22,410 Aug 04 04:02 PM Rodda Julianne EVP, CHIEF PEOPLE OFFICER Aug 03 '26 Sale 122.12 2,112 257,919 18,201 Aug 04 04:01 PM Patterson Chad CHIEF COMM & PRODUCT OFFICER Aug 03 '26 Sale 122.12 2,712 331,192 55,629 Aug 04 04:01 PM Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH Jul 02 '26 Sale 124.71 1,423 177,462 53,620 Jul 06 04:03 PM Freeman Sean Clinton EVP, Strategy & Corp Devt Jul 02 '26 Sale 124.71 918 114,484 13,641 Jul 06 04:03 PM Shrishrimal Sumi EVP, Chief Risk Officer Jun 02 '26 Sale 108.19 1,716 185,652 40,287 Jun 03 04:16 PM Rosenbaum Marc Wade Chief Accounting Officer Jun 02 '26 Sale 108.19 729 78,870 16,155 Jun 03 04:15 PM TALWALKAR ABHIJIT Y Director May 11 '26 Buy 10.71 5,312 56,892 25,611 May 12 05:12 PM TALWALKAR ABHIJIT Y Director May 11 '26 Sale 117.93 5,312 626,430 20,299 May 12 05:12 PM ABHIJIT Y TALWALKAR Director May 11 '26 Proposed Sale 117.93 5,312 626,429 May 11 05:04 PM Lawrence Brian Lee Chief Technology Officer May 04 '26 Sale 120.80 1,014 122,491 20,154 May 05 04:36 PM Smith Mervin EVP Strategic Business Ops Mar 16 '26 Sale 114.30 2,585 295,466 23,027 Mar 17 04:31 PM MERVIN SMITH Officer Mar 16 '26 Proposed Sale 114.30 2,585 295,466 Mar 16 04:13 PM Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH Mar 02 '26 Sale 128.45 4,027 517,259 54,906 Mar 03 06:42 PM Shrishrimal Sumi EVP, Chief Risk Officer Mar 02 '26 Sale 128.44 2,830 363,484 41,870 Mar 03 06:39 PM Smith Mervin EVP Strategic Business Ops Mar 02 '26 Sale 128.44 1,352 173,652 25,612 Mar 03 06:38 PM Patterson Chad CHIEF COMM & PRODUCT OFFICER Mar 02 '26 Sale 128.44 4,444 570,804 58,164 Mar 03 06:37 PM Murphy Patrick Michael CBO and CLO Mar 02 '26 Sale 128.44 4,357 559,624 63,203 Mar 03 06:34 PM Rosenbaum Marc Wade Chief Accounting Officer Mar 02 '26 Sale 128.45 816 104,815 16,706 Mar 03 06:34 PM Wilson Daniel G. Chief Financial Officer Mar 02 '26 Sale 128.45 3,395 436,076 35,660 Mar 03 06:21 PM Blackford Quentin S. President and CEO Mar 02 '26 Sale 128.44 13,813 1,774,174 204,155 Mar 03 06:21 PM Wilson Daniel G. Chief Financial Officer Feb 25 '26 Sale 135.42 5,188 702,553 30,694 Feb 26 05:59 PM Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH Feb 25 '26 Sale 135.42 7,804 1,056,809 48,899 Feb 26 05:56 PM Smith Mervin EVP Strategic Business Ops Feb 25 '26 Sale 135.42 4,041 547,228 20,275 Feb 26 05:52 PM Shrishrimal Sumi EVP, Chief Risk Officer Feb 25 '26 Sale 135.42 6,217 841,899 39,182 Feb 26 05:47 PM Rosenbaum Marc Wade Chief Accounting Officer Feb 25 '26 Sale 135.42 4,797 649,604 15,014 Feb 26 05:43 PM Patterson Chad CHIEF COMM & PRODUCT OFFICER Feb 25 '26 Sale 135.42 8,967 1,214,301 51,738 Feb 26 05:38 PM Murphy Patrick Michael CBO and CLO Feb 25 '26 Sale 135.42 7,805 1,056,945 60,536 Feb 26 05:20 PM Blackford Quentin S. President and CEO Feb 25 '26 Sale 135.42 25,540 3,458,599 186,126 Feb 26 05:14 PM Rosenbaum Marc Wade Chief Accounting Officer Feb 24 '26 Sale 140.91 280 39,455 10,601 Feb 25 07:00 PM Smith Mervin EVP Strategic Business Ops Feb 24 '26 Sale 140.91 732 103,146 15,106 Feb 25 06:58 PM TALWALKAR ABHIJIT Y Director Feb 23 '26 Option Exercise 10.71 5,312 56,892 25,611 Feb 24 05:17 PM TALWALKAR ABHIJIT Y Director Feb 23 '26 Sale 145.70 5,312 773,980 20,299 Feb 24 05:17 PM MERVIN SMITH Officer Feb 24 '26 Proposed Sale 140.91 732 103,146 Feb 24 04:16 PM MARC ROSENBAUM Officer Feb 24 '26 Proposed Sale 140.91 280 39,455 Feb 24 04:10 PM ABHIJIT Y TALWALKAR Director Feb 23 '26 Proposed Sale 145.70 5,312 773,981 Feb 23 04:24 PM Patterson Chad CHIEF COMM & PRODUCT OFFICER Dec 02 '25 Sale 184.83 280 51,752 43,387 Dec 03 04:35 PM Murphy Patrick Michael CBO and CLO Dec 02 '25 Sale 184.83 2,478 458,009 53,281 Dec 03 04:35 PM CHAD PATTERSON Officer Dec 02 '25 Proposed Sale 184.83 280 51,752 Dec 02 04:01 PM TALWALKAR ABHIJIT Y Director Nov 10 '25 Option Exercise 10.71 5,312 56,892 25,611 Nov 12 04:33 PM TALWALKAR ABHIJIT Y Director Nov 10 '25 Sale 174.13 5,312 924,962 20,299 Nov 12 04:33 PM ABHIJIT Y TALWALKAR Director Nov 10 '25 Proposed Sale 174.13 5,312 924,962 Nov 10 04:02 PM Blackford Quentin S. President and CEO Nov 03 '25 Sale 182.94 14,059 2,571,907 164,979 Nov 04 05:04 PM Wilson Daniel G. Chief Financial Officer Oct 31 '25 Sale 207.44 8,000 1,659,520 26,470 Nov 03 04:30 PM DANIEL WILSON Officer Oct 31 '25 Proposed Sale 207.44 8,000 1,659,520 Oct 31 04:07 PM
iRhythm Holdings, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
President Mr. Quentin S. Blackford
CFO & Principal Financial Officer Mr. Daniel G. Wilson
M.S. Dr. Minang P. Turakhia M.D.
Chief Business & Legal Officer Mr. Patrick Michael Murphy J.D.
Chief Commercial and Product Officer Mr. Chad M. Patterson